UK Study Shows Promise for Epithelioid Mesothelioma Patients

In this study, it accounted for 73 of the 103 cases — or 71.5 percent. Those generally responded best to treatment. The one, two and five-year survival rates for epithelial types in the study were 94.5 percent, 76.5 percent and 30.7 percent, respectively. The patients were from January 2004 to December 2013. Almost half still are alive, according to the study report. Median age of the patients was 64.7 years at time of surgery and 24 patients were older than 70. The overall median survival was 32 months, considerably longer than the estimated 6-18 months that patients often survive in the U.S. if they don't find a mesothelioma specialty center. The overall five-year survival rate in the study was 23.1 percent. The two-year survival was 62.9 percent. Non-epithelial patients had a median survival rate of just 15 months and a five-year survival rate of just seven percent. No Early Mortality with P/D Surgery There was no 30-day or 90-day mortality of the study patients, although 30 percent of the patients experienced post-operative complications. All but four patients received from 4-6 cycles of systemic chemotherapy before surgery. Many also received it after surgery. His most successful patients were among the 46 who had both the epithelial mesothelioma and relatively early diagnosis, allowing for complete macroscopic resection of the disease during surgery. The one, two and five-year survival rates of that group were 97.8 percent, 87.4 percent and 40.2 percent. One of his...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: Treatment & Doctors Source Type: news